Rockwell Medical (RMTI) Total Debt Growth (1y) (2014 - 2026)
Rockwell Medical (RMTI) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 41.53% |
| 10 | Rockwell Medical | 29.87 Mn | 5.07 Mn | 3.24 Mn | -19.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.24% |
| Mar 31, 2026 | -18.93% |
| Dec 31, 2025 | -9.38% |
| Sep 30, 2025 | -1.13% |
| Jun 30, 2025 | 3.27% |
| Mar 31, 2025 | 2.14% |
| Dec 31, 2024 | 0.46% |
| Sep 30, 2024 | 82.76% |
| Jun 30, 2024 | 101.25% |
| Mar 31, 2024 | 243.82% |
| Dec 31, 2023 | 405.76% |
| Sep 30, 2023 | -58.62% |
| Jun 30, 2023 | -65.40% |
| Mar 31, 2023 | -82.99% |
| Dec 31, 2022 | -89.62% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -26.65% |
| Mar 31, 2022 | -13.21% |
| Dec 31, 2021 | -2.43% |
| Sep 30, 2021 | -32.88% |